Skip to main content
S 1142 111th Congress Senate Health Administrative law and regulatory procedures Consumer affairs Department of Health and Human Services Food and Drug Administration (FDA) Government information and archives Marketing and advertising Prescription drugs Product safety and quality

Informed Health Care Decision Making Act

Introduced: May 21, 2009 Introduced by: Reed, Jack Democratic · Rhode Island See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 111th Congress ended
It never became law before the 111th Congress (2009–2010) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2009
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5849-5850)
May 21, 2009
Sponsor introductory remarks on measure. (CR S5848-5849)
May 21, 2009
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Informed Health Care Decision Making Act - Requires the Commissioner of Food and Drugs (FDA) to: (1) determine whether standardized, quantitative summaries of the benefits and risks of drugs in a tabular or drug facts box format would improve health care decisionmaking by clinicians, patients, and consumers; and (2) establish and update standards for comparative clinical effectiveness information in the labeling and advertising of drugs and devices under the Federal Food, Drug, and Cosmetic Act. Defines "comparative clinical effectiveness" as the clinical outcomes, effectiveness, safety, and clinical appropriateness of a drug or device in comparison to one or more drugs or devices approved to prevent, diagnose, or treat the same health condition in the same patient demographic subpopulation.

Amends the Federal Food, Drug, and Cosmetic Act to require information on comparative clinical effectiveness for drugs and devices in labeling and advertising.

What's happening now May 21, 2009

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5849-5850)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1142: Informed Health Care Decision Making Act. 111th Congress. Open America. https://openamerica.io/bill/111-S-1142/
MLA
"S. 1142: Informed Health Care Decision Making Act." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-S-1142/.
Bluebook (legal)
S. 1142, 111th Cong. (2026), https://openamerica.io/bill/111-S-1142/.
Markdown link
[S. 1142: Informed Health Care Decision Making Act](https://openamerica.io/bill/111-S-1142/)
Report a problem